Cronos Group (CVE:MJN) Stock Price Down 1.9% – Should You Sell?

Cronos Group Inc (CVE:MJNGet Free Report) dropped 1.9% on Friday . The stock traded as low as C$11.90 and last traded at C$12.15. Approximately 1,388,975 shares changed hands during mid-day trading, a decline of 33% from the average daily volume of 2,065,952 shares. The stock had previously closed at C$12.38.

Cronos Group Trading Down 1.9%

The stock has a fifty day moving average of C$12.15 and a 200-day moving average of C$12.15.

Cronos Group Company Profile

(Get Free Report)

Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada’s Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals.

Featured Articles

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.